Interleukin-33 induces mucin gene expression and goblet cell hyperplasia in human nasal epithelial cells

Hajime Ishinaga1, Masako Kitano1, Masaaki Toda2

  • 1Department of Otorhinolaryngology-Head & Neck Surgery, Mie University Graduate School of Medicine, Japan.

Cytokine
|November 7, 2016
PubMed

Insights

Interleukin-33 (IL-33) drives mucus overproduction and goblet cell hyperplasia in eosinophilic chronic rhinosinusitis (ECRS). This finding reveals IL-33

Area of Science:

  • Immunology
  • Respiratory Medicine
  • Molecular Biology

Background:

  • Eosinophilic chronic rhinosinusitis (ECRS) is characterized by airway inflammation and mucus hypersecretion.
  • The precise molecular mechanisms driving mucus overproduction in ECRS require further elucidation.

Purpose of the Study:

  • To investigate the role of Interleukin-33 (IL-33) in mucus overproduction and goblet cell hyperplasia in ECRS.

Main Methods:

  • Quantitative analysis of IL-33 mRNA levels in human nasal polyps from ECRS patients.
  • In vitro air-liquid interface culture of human nasal epithelial cells to assess IL-33's effects on mucin gene and protein expression.
  • Evaluation of goblet cell hyperplasia following IL-33 stimulation.

Main Results:

  • Significantly elevated IL-33 mRNA levels were observed in eosinophilic CRS compared to non-eosinophilic CRS.
  • IL-33 stimulation led to increased MUC5AC mRNA and protein expression.
  • IL-33 induced goblet cell hyperplasia and altered the expression of other key genes (MUC5B, FOXA3, FOXJ1).

Conclusions:

  • IL-33 directly promotes mucin gene and protein expression, contributing to mucus overproduction in ECRS.
  • This study provides direct evidence for IL-33's role in goblet cell hyperplasia and mucus dysregulation in eosinophilic airway inflammation.

Related Concept Videos